profit from every $100 of sales.
$0$100
Ekso Bionics Holdings
$9.95-8.38% today
+114.0% in 1 year
1-year low $4.651-year high $29.63
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Ekso Bionics Holdings vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Ekso Bionics Holdings | No profit yet | ||
 Takara Bio | 130.9× · Very expensive | ||
 Mobia Medical | No profit yet | ||
 Shoulder Innovations | No profit yet | ||
 Edap Tms | No profit yet |
AI analysis
An AI analyst reads Ekso Bionics Holdings's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2025 |
|---|---|
| 84 | |
| -31 | |
| -58 | |
| 25 | |
| -73 | |
| – | |
| -36.7% | |
| -68.3% | |
| -86.2% |
Balance sheet
| In millions of USD | 2025 |
|---|---|
| Total assets | 304 |
| Cash | 2 |
| Total debt | 220 |
| Total liabilities | 228 |
| 76 | |
| – | |
| -14.8% | |
| -95.5% |
Cash flow
| In millions of USD | 2025 |
|---|---|
| -7 | |
| 1 | |
| -9 | |
| Dividends paid | – |
| – | |
| -1 |
Valuation
- –
- –
- –
- –
- 17.1×
- –
- 65.6×
- -0.6%
- -5.0%
- –
Profitability
- -36.7%
- -68.3%
- -86.2%
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 5%of 894
Bottom 33%of 991
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Feb 23, 2026 | -1.56 | -0.29 | −443.3% |
News
ChronoScale Says It Plans a 50 MW Microsoft AI Deployment. Can CHRN Fund the Build Without Diluting Shareholders?Yahoo Finance · Sep 4, 2026The newest story we have is from Sep 4, 2026.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about Ekso Bionics Holdings
Is Ekso Bionics Holdings a good stock to buy?
A business with weak numbers that is not profitable yet. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Ekso Bionics Holdings AI analysis
What does Ekso Bionics Holdings do?
Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA. It is in Medical - Specialties, based in Dallas, TX, United States.
Does Ekso Bionics Holdings pay a dividend?
No. Ekso Bionics Holdings does not pay a dividend at the moment.
Is Ekso Bionics Holdings stock halal?
Yes. Ekso Bionics Holdings passes our halal screen: its business is permitted and its debt is 15% of its market value, under the 30% limit. How we check
How has Ekso Bionics Holdings stock done over the past year?
Up 114.0% over the past twelve months, to $9.95. It traded between $4.65 and $29.63 and is 66.4% below its high.
Who are Ekso Bionics Holdings's competitors?
The largest listed companies in the same industry are Takara Bio, Mobia Medical, Shoulder Innovations and Edap Tms. The peers table on this page compares their profit, growth and price with Ekso Bionics Holdings's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.